GCC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.480200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.245200E-01
Normal-vs-Stage2
5.832000E-01
Normal-vs-Stage3
9.098300E-02
Normal-vs-Stage4
1.369970E-01
Stage1-vs-Stage2
9.821400E-01
Stage1-vs-Stage3
7.771900E-02
Stage1-vs-Stage4
2.235400E-01
Stage2-vs-Stage3
4.497700E-02
Stage2-vs-Stage4
1.162170E-01
Stage3-vs-Stage4
1.129960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.642000E-01
Normal-vs-AfricanAmerican
4.358600E-01
Normal-vs-Asian
7.845600E-01
Caucasian-vs-AfricanAmerican
2.911200E-01
Caucasian-vs-Asian
9.630200E-01
AfricanAmerican-vs-Asian
5.230800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.626000E-01
Normal-vs-Female
7.641400E-01
Male-vs-Female
2.669000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.875600E-01
Normal-vs-Age(41-60Yrs)
3.791400E-01
Normal-vs-Age(61-80Yrs)
7.982400E-01
Normal-vs-Age(81-100Yrs)
8.717800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.355600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.380200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.467000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.033830E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.642300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.164800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.615400E-01
Normal-vs-Daily Drinker
9.238400E-01
Normal-vs-Weekly Drinker
9.641000E-01
Normal-vs-Occasional Drinker
3.107600E-01
Normal-vs-Social Drinker
5.621800E-01
Non Drinker-vs-Daily Drinker
5.742400E-01
Non Drinker-vs-Weekly Drinker
6.864600E-01
Non Drinker-vs-Occasional Drinker
8.688300E-02
Non Drinker-vs-Social Drinker
5.424000E-01
Daily Drinker-vs-Weekly Drinker
9.186800E-01
Daily Drinker-vs-Occasional Drinker
5.104000E-02
Daily Drinker-vs-Social Drinker
3.087000E-01
Weekly Drinker-vs-Occasional Drinker
7.505600E-02
Weekly Drinker-vs-Social Drinker
3.521000E-01
Occasional Drinker-vs-Social Drinker
2.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.460200E-02
Normal-vs-Grade 2
1.746290E-02
Normal-vs-Grade 3
7.324100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.381830E-01
Grade 1-vs-Grade 3
6.812000E-02
Grade 1-vs-Grade 4
7.460200E-02
Grade 2-vs-Grade 3
5.610200E-01
Grade 2-vs-Grade 4
1.746290E-02
Grade 3-vs-Grade 4
7.324100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.271600E-01
Normal-vs-NonDiabetic
7.341400E-01
Diabetic-vs-NonDiabetic
3.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.843000E-01
Normal-vs-NoPancreatitis
7.286800E-01
Pancreatitis-vs-NoPancreatitis
5.193800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.956400E-01
Normal-vs-N1
6.097200E-01
N0-vs-N1
7.225800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.178000E-01
Normal-vs-TP53-NonMutant
5.904400E-01
TP53-Mutant-vs-TP53-NonMutant
2.581000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
